A Study of Buntanetap in Participants With PD
Trial details
- Registry ID
- NCT07284784
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
Also recorded as ANVS401; Posiphen Tartrate
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Buntanetap in Participants With PDNCT07284784 | ANVS | Phase 2, Phase 3 | Recruiting | 2029-09Estimated |
| A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDNCT05357989 | ANVS | Phase 3 | Completed | 2023-12-04Actual |
| A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADNCT06709014 | ANVS | Phase 3 | Active not recruiting | 2027-12Estimated |
| An Open-label Long-term Safety Study of Buntanetap in Participants With ADNCT07757204 | ANVS | Phase 2, Phase 3 | Not yet recruiting | 2030-02-21Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |